Lipidome profiling with Raman microspectroscopy identifies macrophage response to surface topographies of implant materials.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
28 12 2021
Historique:
accepted: 16 11 2021
entrez: 22 12 2021
pubmed: 23 12 2021
medline: 12 2 2022
Statut: ppublish

Résumé

Biomaterial characteristics such as surface topographies have been shown to modulate macrophage phenotypes. The standard methodologies to measure macrophage response to biomaterials are marker-based and invasive. Raman microspectroscopy (RM) is a marker-independent, noninvasive technology that allows the analysis of living cells without the need for staining or processing. In the present study, we analyzed human monocyte-derived macrophages (MDMs) using RM, revealing that macrophage activation by lipopolysaccharides (LPS), interferons (IFN), or cytokines can be identified by lipid composition, which significantly differs in M0 (resting), M1 (IFN-γ/LPS), M2a (IL-4/IL-13), and M2c (IL-10) MDMs. To identify the impact of a biomaterial on MDM phenotype and polarization, we cultured macrophages on titanium disks with varying surface topographies and analyzed the adherent MDMs with RM. We detected surface topography-induced changes in MDM biochemistry and lipid composition that were not shown by less sensitive standard methods such as cytokine expression or surface antigen analysis. Our data suggest that RM may enable a more precise classification of macrophage activation and biomaterial-macrophage interaction.

Identifiants

pubmed: 34934001
pii: 2113694118
doi: 10.1073/pnas.2113694118
pmc: PMC8719892
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Cytokines 0
Lipopolysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Biomed Mater Res A. 2017 Sep;105(9):2562-2571
pubmed: 28544348
Science. 2017 Jun 9;356(6342):1026-1030
pubmed: 28596335
Front Immunol. 2020 Jan 10;10:2993
pubmed: 31998297
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Biomaterials. 2014 May;35(15):4477-88
pubmed: 24589361
Cell Metab. 2011 May 4;13(5):540-9
pubmed: 21531336
Analyst. 2016 Jun 21;141(12):3590-600
pubmed: 27072718
Sci Rep. 2017 Aug 21;7(1):8965
pubmed: 28827726
Acta Biomater. 2016 Feb;31:425-434
pubmed: 26675126
Cell. 2014 May 8;157(4):832-44
pubmed: 24792964
Biomaterials. 2012 Jun;33(16):4136-46
pubmed: 22417617
J Mech Behav Biomed Mater. 2018 Dec;88:377-385
pubmed: 30205325
Spine (Phila Pa 1976). 2016 Apr;41 Suppl 7:S30-1
pubmed: 27015070
Sci Rep. 2019 May 7;9(1):7014
pubmed: 31065074
Biomed Mater. 2017 Apr 28;12(2):025021
pubmed: 28452335
Differentiation. 2014 Jan-Feb;87(1-2):66-75
pubmed: 24565918
Faraday Discuss. 2004;126:141-57; discussion 169-83
pubmed: 14992404
Sci Rep. 2014 Apr 15;4:4698
pubmed: 24732136
Acta Biomater. 2018 Apr 15;71:247-260
pubmed: 29518556
Matrix Biol. 2020 Jan;85-86:205-220
pubmed: 31238092
Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:143-151
pubmed: 30573235
Biochim Biophys Acta. 2013 Jul;1832(7):989-97
pubmed: 23246690
J Biomed Mater Res A. 2013 Sep;101(9):2679-88
pubmed: 23427077
Int J Biol Sci. 2014 May 01;10(5):520-9
pubmed: 24910531
Adv Drug Deliv Rev. 2017 May 15;114:184-192
pubmed: 28712923
J Biophotonics. 2013 Feb;6(2):205-11
pubmed: 22678997
Atherosclerosis. 2011 Jun;216(2):313-20
pubmed: 21411094
Lipids. 2004 May;39(5):407-19
pubmed: 15506235
Sci Rep. 2018 Aug 22;8(1):12604
pubmed: 30135442
Clin Chem. 1981 Mar;27(3):493-501
pubmed: 7471403
PLoS One. 2018 Dec 7;13(12):e0208602
pubmed: 30532146
Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150202
pubmed: 26953178
Br J Nutr. 2009 Aug;102(4):497-501
pubmed: 19660150
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3809-14
pubmed: 21310969
Adv Wound Care (New Rochelle). 2012 Feb;1(1):10-16
pubmed: 24527272
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
Cell J. 2013 Fall;15(3):218-23
pubmed: 24027662
Acta Biomater. 2019 Apr 15;89:193-205
pubmed: 30878445
Inflamm Res. 2019 Nov;68(11):915-932
pubmed: 31363792
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9415-20
pubmed: 23690624
Front Bioeng Biotechnol. 2020 Apr 07;8:292
pubmed: 32318563
J Biomed Mater Res A. 2005 Jul 1;74(1):49-58
pubmed: 15924300
Implant Dent. 2018 Dec;27(6):672-681
pubmed: 30475272
J Nutr Biochem. 2018 Jul;57:121-129
pubmed: 29698923
Colloids Surf B Biointerfaces. 2019 Sep 1;181:125-133
pubmed: 31128512
Cell Death Dis. 2020 Feb 19;11(2):136
pubmed: 32075954
J Biomed Mater Res A. 2017 Jan;105(1):138-147
pubmed: 27601305
Acta Biomater. 2018 Jan 15;66:213-223
pubmed: 29107632
Prostaglandins Other Lipid Mediat. 2016 Dec;127:1-8
pubmed: 27871801
Cell Metab. 2015 Jan 6;21(1):65-80
pubmed: 25565206
J Lipid Res. 2017 May;58(5):876-883
pubmed: 28143895
Biomaterials. 1984 Jan;5(1):5-10
pubmed: 6375747
Trends Cell Biol. 2018 Dec;28(12):1030-1048
pubmed: 30309735
Phys Chem Chem Phys. 2020 Oct 7;22(38):21646-21650
pubmed: 32985622
Anal Chem. 2012 Oct 16;84(20):8549-56
pubmed: 22954250
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2676-E2685
pubmed: 29511099

Auteurs

Nora Feuerer (N)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.
Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.

Julia Marzi (J)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.
Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Cluster of Excellence "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, 72076 Tübingen, Germany.

Eva M Brauchle (EM)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.
Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Cluster of Excellence "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, 72076 Tübingen, Germany.

Daniel A Carvajal Berrio (DA)

Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Cluster of Excellence "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, 72076 Tübingen, Germany.

Florian Billing (F)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.

Martin Weiss (M)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.
Department of Women's Health, Research Institute for Women's Health, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.

Meike Jakobi (M)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.

Nicole Schneiderhan-Marra (N)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.

Christopher Shipp (C)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany.

Katja Schenke-Layland (K)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany; katja.schenke-layland@uni-tuebingen.de.
Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Cluster of Excellence "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Department of Medicine, Division of Cardiovascular Medicine, University of California, Los Angeles, CA 90095.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH